Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/003090 stock hub

KRX/003090 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/003090is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

907.8B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/003090

In the news

Latest news · KRX/003090

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E5.2

P25 12P50 23.1P75 39.5

ROE13.9

P25 -17.1P50 0.7P75 8.5

ROIC10.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/003090 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

KRW

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	379
Enterprise value	KRW 2.1T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7003090008
Last refreshed	2026-05-10
Market cap	KRW 907.8B
Price	KRW 22,200
Price currency	KRW
Rev Per Employee	5,457,441,833.77x
Sector	Healthcare
Sic	2834
Symbol	krx/003090
Website	https://www.daewoongholdings.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	19.28%
EV Earnings	11.94x
EV/EBIT	7.09x
EV/EBITDA	5.84x
EV/FCF	-24.22x
EV/Sales	1.01x
FCF yield	-9.51%
P/B ratio	0.51x
P/E ratio	5.19x
P/S ratio	0.44x
PE Ratio10 Y	14.96x
PE Ratio3 Y	7.95x
PE Ratio5 Y	9.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.6%
EBITDA Margin	15.64%
Gross margin	53.34%
Gross Profit	KRW 1.1T
Gross Profit Growth	5.18%
Gross Profit Growth Q	-2.58%
Gross Profit Growth3 Y	7.08%
Gross Profit Growth5 Y	12.03%
Net Income	KRW 175.1B
Net Income Growth	202.43%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	19.51%
Net Income Growth5 Y	12.22%
Pretax Margin	11.78%
Profit Margin	8.46%
Profit Per Employee	KRW 461.9M
Profitable Years	20
ROA	5.47
Roa5y	6.02
ROCE	10.58
ROE	13.94
Roe5y	10.28
ROIC	10.79
Roic5y	11.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.36%
Cagr15y	14.68%
Cagr1y	16.31%
Cagr20y	10.46%
Cagr3y	14.58%
Cagr5y	-7.7%
Div CAGR10	7.18%
Div CAGR3	25.99%
Div CAGR5	14.87%
EPS Growth	202.3
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	20.16
EPS Growth5 Y	12.81
OCF Growth	58.62%
OCF Growth Q	26.03%
OCF Growth10 Y	13.14%
OCF Growth3 Y	19.99%
OCF Growth5 Y	12.12%
Revenue Growth	6.79x
Revenue Growth Q	2.47x
Revenue Growth Quarters	20x
Revenue Growth Years	5x
Revenue Growth3 Y	6.81x
Revenue Growth5 Y	8.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.69
Assets	KRW 3.2T
Cash	KRW 285.8B
Current Assets	KRW 1T
Current Liabilities	KRW 769.8B
Debt	KRW 878.2B
Debt EBITDA	KRW 2.72
Debt Equity	KRW 0.5
Debt FCF	KRW -10.17
Equity	KRW 1.8T
Interest Coverage	18.79
Liabilities	KRW 1.5T
Long Term Assets	KRW 2.2T
Long Term Liabilities	KRW 695.1B
Net Cash	KRW -592.4B
Net Cash By Market Cap	KRW -65.26
Net Debt EBITDA	KRW 1.83
Net Debt Equity	KRW 0.34
Tangible Book Value	KRW 1T
Tangible Book Value Per Share	KRW 25,044
WACC	4.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.34
Inventory Turnover	2.31
Net Working Capital	KRW 302.6B
Quick ratio	0.71
Working Capital	KRW 262.6B
Working Capital Turnover	KRW 8.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.06%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 200
Dividend Years	33
Dividend Yield	0.9%
Ex Div Date	2025-12-29
Last Dividend	KRW 200
Payout Frequency	Annual
Payout Ratio	7.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	103.44%
1Y total return	16.3%
200-day SMA	23,452
3Y total return	50.44%
50-day SMA	23,515
50-day SMA vs 200-day SMA	50over200
5Y total return	-33%
All Time High	86,700
All Time High Change	-74.39%
All Time High Date	2020-12-22
All Time Low	481.8
All Time Low Change	4,507.53%
All Time Low Date	1998-09-22
ATR	747.5
Beta	0.42
Beta1y	0.38
Beta2y	0.45
Ch YTD	0.68
High	22,500
High52	30,600
High52 Date	2026-02-23
High52ch	-27.45%
Low	21,700
Low52	18,870
Low52 Date	2025-05-28
Low52ch	17.65%
Ma50ch	-5.59%
Price vs 200-day SMA	-5.34%
RSI	42.96
RSI Monthly	49.6
RSI Weekly	45.07
Sharpe ratio	0.39x
Sortino ratio	0.8
Total Return	0.84%
Tr YTD	0.68
Tr15y	680.52%
Tr1m	1.14%
Tr1w	-0.89%
Tr3m	-6.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 260.5B
Operating Income Growth	-6.7
Operating Income Growth Q	-44.49
Operating Income Growth3 Y	7.91
Operating Income Growth5 Y	21.58
Operating margin	12.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,474,302%
Net Borrowing	187,834,914,140
Shares Insiders	42.22%
Shares Institutions	9.64%
Shares Out	40,890,710
Shares Qo Q	0.12%
Shares Yo Y	0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -87.1B
Average Volume	65,907.2x
Bv Per Share	28,741.9
CAPEX	KRW -343.9B
Ch10y	90.72
Ch15y	564.7
Ch1m	1.14
Ch1w	-0.89
Ch1y	15.27
Ch20y	459.1
Ch3m	-6.33
Ch3y	46.92
Ch5y	-35.09
Ch6m	2.07
Change	1.14%
Change From Open	0.45
Close	21,950
Days Gap	0.68
Depreciation Amortization	62,884,988,000
Dollar Volume	1,178,220,600
Earnings Date	2026-05-15
EBIT	KRW 260.5B
EBITDA	KRW 323.4B
EPS	KRW 4,280
F Score	5
FCF	KRW -86.3B
FCF EV Yield	-4.13x
FCF Per Share	KRW -2,111
Financing CF	175,078,459,120
Fiscal Year End	December
Founded	1,945
Goodwill	63,612,899,000
Graham Number	52610.31764
Graham Upside	137
Income Tax	KRW 15.7B
Investing CF	-367,518,409,410
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2017-04-26
Last Split Type	Forward
Lynch Fair Value	KRW 52,289
Lynch Upside	135.5
Ma150	23,331.3
Ma150ch	-4.85%
Ma20	22,750
Ma20ch	-2.42%
Net CF	64,396,696,770
Next Earnings Date	2026-05-15
Open	22,100
P OCF Ratio	3.52
Payment Date	2026-04-10
Position In Range	62.5
Ppne	1,172,630,666,860
Price Date	2026-05-08
Price EBITDA	KRW 2.81
Ptbv Ratio	0.89
Relative Volume	0.77x
Revenue	2,068,370,455,000x
SBC By Revenue	0.04x
Share Based Comp	775,428,000
Tax By Revenue	0.76x
Tax Rate	6.45%
Tr20y	630.64%
Tr6m	2.98%
Volume	53,073
Z Score	1.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/003090 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$200 annual per share

Payout ratio

+7.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+14.9%

0 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2025-12-29

Performance

KRX/003090 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/003090?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.6%

Share of float held by funds and institutions

Insider ownership

+42.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

KRX/003090 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.0

Neutral momentum band

Price vs 200-day MA

-5.3%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

0.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/003090

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/003090 stock rating?

krx/003090 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/003090 analysis?

The full report lives at /stocks/krx/003090/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/003090?

The latest report frames krx/003090 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/003090 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.